ArticleAnnals of surgical oncology2026
Robotic-Assisted Cytoreductive Surgery for Recurrent Endometrial Carcinoma with Iliac Vessel Involvement: A Multidisciplinary Approach.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASO Author Reflections: Robotic Cytoreduction at the Vascular Interface: Redefining Surgical Limits.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRecurrent endometrial carcinoma involving major pelvic vasculature poses significant surgical challenges, particularly when residual disease persists after systemic therapy and radiation is contraindicated. Robotic-assisted surgery offers a minimally invasive solution for precise tumor dissection near critical vessels. CASE REPORT: A 67-year-old woman with recurrent endometrial carcinoma presented with deep vein thrombosis and pulmonary embolism 3 years after primary treatment with hysterectomy, chemotherapy, and brachytherapy. Imaging revealed a 5-cm pelvic mass encasing the right external iliac vessels and two lung nodules. After six cycles of carboplatin and liposomal doxorubicin, lung lesions resolved, but the pelvic mass persisted. OPERATIVE TECHNIQUE: A multidisciplinary team, including gynecologic oncologists and vascular surgeons, performed a robotic-assisted secondary cytoreductive surgery. A prophylactic iliac vein balloon was placed by the vascular team but remained uninflated. The procedure involved adhesiolysis, retroperitoneal dissection, and careful tumor separation from the external and internal iliac vessels with vascular preservation. Metal clips were applied to guide postoperative radiation planning. The tumor was completely resected without vascular injury. The patient recovered uneventfully and was discharged on postoperative Day 1.
conclusionsThis case underscores the feasibility and safety of a multidisciplinary robotic-assisted approach for pelvic tumor resection involving major vasculature. Preoperative vascular planning and endovascular readiness enhance surgical safety, while minimally invasive techniques offer improved recovery and precision in managing recurrent endometrial carcinoma.
Indexed as
Identifiers
42143650What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.